Table 2 Rankings of performance management (PM) research directions overall and by end-user group
Research directions (RDs) | |||||
|---|---|---|---|---|---|
End-user group | RD1 Use of PM | RD2 PM in high-performing systems | RD3 Influence of context | RD4 Motivating improvement | RD5 Unintended negative consequences |
All end-users (n = 156) | 2.90 | 2.93 | 2.95 | 2.68 | 3.52 |
CCO cancer staff (n = 50) | 2.3 | 3.0 | 3.7 | 2.6 | 3.5 |
CCO renal staff (n = 9) | 3.2 | 1.8 | 3.1 | 2.6 | 4.3 |
Network cancer staff (n = 52) | 3.3 | 3.0 | 2.6a | 2.6 | 3.5 |
Network renal staff (n = 36) | 3.1 | 3.2 | 2.4 | 2.9 | 3.2 |
External end-users (e.g., patients, policy-makers) (n = 9) | 2.8 | 2.1 | 3.3 | 2.4 | 4.3 |